Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lenormand

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
FEBS Letters|November 24, 1999
MyoD binds to Mos and inhibits the Mos/MAP kinase pathwayB Solhonne, J L Lenormand, K Pelpel, et al.
FEBS Letters|March 20, 1995
Myogenin binds to and represses c-fos promoterD Trouche, H Masutani, R Groisman, et al.
The EMBO Journal|April 15, 1999
Speedy: a novel cell cycle regulator of the G2/M transitionJ L Lenormand, R W Dellinger, K E Knudsen, et al.
Molecular and Cellular Biology|February 1, 1997
Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteinsJ L Lenormand, B Benayoun, M Guillier, et al.
Oncogene|August 1, 1990
Rat myogenic c-mos cDNA: cloning sequence analysis and regulation during muscle developmentS A Leibovitch, J L Lenormand, M P Leibovitch, et al.
Biochemical and Biophysical Research Communications|October 13, 2005
High level production of secreted proteins: example of the human tissue inhibitor of metalloproteinases 1L Crombez, B Marques, J L Lenormand, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 31, 2011
[Laparoscopic sacrocolpopexy results contingent on mesh position]E Leveau, O Bouchot, P-A Lehur, et al.
European Urology|November 30, 2000
Intermittent androgen suppression in the treatment of metastatic prostate cancerO Bouchot, L Lenormand, G Karam, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 5, 2013
[Post-traumatic syringomyelia: What should know the urologist?]R Caremel, O Hamel, E Gerardin, et al.
Nature|May 6, 1993
Repression of c-fos promoter by MyoD on muscle cell differentiationD Trouche, M Grigoriev, J L Lenormand, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
FEBS Letters|November 24, 1999
MyoD binds to Mos and inhibits the Mos/MAP kinase pathwayB Solhonne, J L Lenormand, K Pelpel, et al.
FEBS Letters|March 20, 1995
Myogenin binds to and represses c-fos promoterD Trouche, H Masutani, R Groisman, et al.
The EMBO Journal|April 15, 1999
Speedy: a novel cell cycle regulator of the G2/M transitionJ L Lenormand, R W Dellinger, K E Knudsen, et al.
Molecular and Cellular Biology|February 1, 1997
Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteinsJ L Lenormand, B Benayoun, M Guillier, et al.
Oncogene|August 1, 1990
Rat myogenic c-mos cDNA: cloning sequence analysis and regulation during muscle developmentS A Leibovitch, J L Lenormand, M P Leibovitch, et al.
Biochemical and Biophysical Research Communications|October 13, 2005
High level production of secreted proteins: example of the human tissue inhibitor of metalloproteinases 1L Crombez, B Marques, J L Lenormand, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 31, 2011
[Laparoscopic sacrocolpopexy results contingent on mesh position]E Leveau, O Bouchot, P-A Lehur, et al.
European Urology|November 30, 2000
Intermittent androgen suppression in the treatment of metastatic prostate cancerO Bouchot, L Lenormand, G Karam, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 5, 2013
[Post-traumatic syringomyelia: What should know the urologist?]R Caremel, O Hamel, E Gerardin, et al.
Nature|May 6, 1993
Repression of c-fos promoter by MyoD on muscle cell differentiationD Trouche, M Grigoriev, J L Lenormand, et al.
Pageof 3